英文論文
2019以前
原著論文
Takei Y, Takahashi S, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.
Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.
PLoS One. 2019 Oct 15;14(10):e0223703.
Mishima K, Nakasatomi M, Takahashi S, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.
Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel.
PLoS One. 2019 Oct 9;14(10):e0223496.
Shibusawa R, Yamada E, Okada S, Nakajima Y, Bastie CC, Maeshima A, Kaira K, Yamada M.
Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death.
Sci Rep. 2019 Jul 8;9(1):9887.
Masuda T, Ohara K, Nagayama I, Matsuoka R, Murakami T, Nakagawa S, Oka K, Asakura M, Igarashi Y, Fukaya Y, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Nagata D.
Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients.
Int Urol Nephrol. 2019 Sep;51(9):1623-1629.
Iriuchishima H, Maeshima A, Takahashi S, Ishizaki T, Yokohama A, Tsukamoto N, Saitoh T, Murakami H, Handa H.
Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.
Biosci Rep. 2019 May 31;39(5). pii: BSR20190206.
Nakasatomi M, Takahashi S, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.
Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF.
PLoS One. 2019 Mar 7;14(3):e0212991.
Nagayama I, Masuda T, Nakagawa S, Murakami T, Ohara K, Matsuoka R, Kobayashi T, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Intern Med. 2019 Jun 1;58(11):1587-1591.
Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, Okada M, Miki A, Myoga A, Sugase T, Sekiguchi C, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Nephrology (Carlton). 2019 Sep;24(9):904-911.
Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K.
Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
Case Rep Rheumatol. 2018 Jul 26;2018:6873276.
Tabei A, Watanabe M, Ikeuchi H, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Kaira K, Hirato J, Nojima Y, Hiromura K.
The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.
Intern Med. 2018 Nov 1;57(21):3135-3139.
Hamatani H, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, Hiromura K.
TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.
Nephrology (Carlton). 2019 May;24(5):575-584.
Mochizuki K, Kayakabe K, Hiromura K, Ando M, Sakurai N, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.
Successful treatment of severe crescentic lupus nephritis by multi-target therapy using tacrolimus and mycophenolate mofetil.
CEN Case Rep. 2015 Nov;4(2):126-130.
Takahashi S, Nakasatomi M, Takei Y, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, MaeshimaA.
Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.
Sci Rep. 2018 Mar 26;8(1):5176.
Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.
Involvement of Infiltrating Macrophage-derived Activin A in the Progression of Renal Damage in MRL-lpr Mice.
Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F297-F304
Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.
Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.
Mod Rheumatol. 2016 Apr 26:1-6.
Sakairi T, Hiromura K, Kaneko Y, Maeshima A, Hirato J, Nojima Y.
Histological findings in the spleen affected by adult-onset Still's disease: a report of three cases.
Clin Exp Rheumatol. 2016 34(3):566-7.
Nakasatomi M, Maeshima A, Mishima K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.
Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats.
Fibrogenesis Tissue Repair. 8: 12. 2015.
Bussolati B, Maeshima A, Peti-Peterdi J, Yokoo T, Lasagni L.
Renal Stem Cells, Tissue Regeneration, and Stem Cell Therapies for Renal Diseases.
Stem Cells Int. 2015: 302792.
Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.
Glomerular cytokine expression in murine lupus nephritis.
Clin Exp Nephrol. 2016 Feb;20(1):23-9
Kanasaki K, Maeshima A, Taduri G, Revuelta I
Combating kidney fibrosis.
Biomed Res Int. 2014;2014:679154. doi: 10.1155/2014/679154. Epub 2014 Sep 7.
Hamatani H, Hiromura K, Sakairi T, Takahashi S, Watanabe M, Maeshima A, Ohse T, Pippin JW, Shankland SJ, Nojima Y.
Expression of a Novel Stress-inducible Protein, Sestrin 2, in Rat Glomerular Parietal Epithelial Cells.
Am J Physiol Renal Physiol 2014 Sep 15;307(6):F708-17
Motohashi R, Ikeuchi H, Hiromura K, Ohishi Y, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.
Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy.
Scand J Gastroenterol. 2014 Oct;49(10): 1270-1
Maeshima A, Mishima K, Yamashita S, Nakasatomi M, Miya M, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K, Hasegawa Y, Kojima I, Nojima Y
Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.
Biomed Res Int. 2014: 376191.
Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Mod Rheumatol. 2014 Jul;24(4):618-25
Takahashi S, Tomioka M, Hiromura K, Sakairi T, Hamatani H, Watanabe M, Ikeuchi H, Kaneko Y, Maeshima A, Aoki T, Ohnishi H, Matozaki T, Nojima Y.
SIRPα signaling regulates podocyte structure and function.
Am J Physiol Renal Physiol. 2013 Sep;305(6):F861-70.
Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y.
Nephrotic Syndrome Caused by Immune-Mediated Acquired LCAT Deficiency.
J Am Soc Nephrol. 2013 Jul;24(8):1305-12
Mishima K, Maeshima A, Miya M, Sakurai N, Ikeuchi H, Hiromura K, Nojima Y.
Involvement of N-type Ca (2+) channels in the fibrotic process of the kidney in rats.
Am J Physiol Renal Physiol. 2013 Mar 15; 304(6): F665-73
Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.
Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.
Rheumatology (Oxford). 2012 Sep;51(9):1639-43
Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y.
Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis.
Rheumatology (Oxford). 2012 Sep;51(9):1571-9
Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Nojima Y.
Age-related decline in label-retaining tubular cells: implication for reduced regenerative capacity after injury in the aging kidney.
Am J Physiol Renal Physiol. 2012 Mar;302(6): F694-702.
Umemoto A, Ikeuchi H, Hiromura K, Hamatani H, Sakurai N, Sakairi T, Matsumoto T, Maeshima A, Kuroiwa T, Nojima Y.
Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener’s).
Mod Rheumatol. 2012 Aug;22(4):616-20
Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Yokoo H, Nojima Y.
Enhancement of In Vitro Human Tubulogenesis by Endothelial Cell-derived Factors: Implications for In Vivo Tubular Regeneration after Injury.
Am J Physiol Renal Physiol. 2011 Aug;301(2):F387-95.
Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
Mod Rheumatol. 2011 Jun;21(3):282-9
Sakairi T, Hiromura K, Takahashi S, Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T, Nojima Y.
Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Nephrology (Carlton). 2011 Jan;16(1):76-86.
Yoshida Y, Fukuda N, Maeshima A, Yamamoto C, Matsumoto T, Ueno T, Nojima Y, Matsumoto K, Soma M.
Treatment with valsartan stimulates endothelial progenitor cells and renal label-retaining cells in hypertensive rats.
J Hypertens. 2011 Jan;29(1):91-101.
Sakurai N, Kuroiwa T, Kayakabe K, Matsumoto T, Maeshima A, Hiromura K, Nojima Y.
Insulin-like growth factor binding protein-related protein 1 is expressed in rheumatoid synovium and regulates synovial fibroblast proliferation.
Mod Rheumatol. 2011 Feb;21(1):63-72.
Tomioka M, Hiromura K, Sakairi T, Takeuchi S, Maeshima A, Kaneko Y, Kuroiwa T, Takeuchi T, Nojima Y.
Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
Nephrology (Carlton). 2010 Aug;15(5):568-74.
Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
Nephron Exp Nephrol. 2010;116(1):e3-10.
Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Takeuchi S, Tomioka M, Shigehara T, Maeshima A, Kaneko Y, Hiromura K, Kopp JB, Nojima Y
Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Nephrol Dial Transplant. 24(8):2378-83, 2009
Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, Kaneko Y, Hiromura K, Nojima Y
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.
Rheumatology (Oxford). 47(6):815-20, 2008
Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y
Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
Rheumatology (Oxford) 47(5):702-7, 2008
Maeshima A, Sakurai H, Choi Y, Kitamura S, Vaughn DA, Tee JB, Nigam SK
Glial cell-derived neurotrophic factor independent ureteric bud outgrowth from the Wolffian duct.
J Am Soc Nephrol 18(12):3147-55, 2007
Ideura H, Hiromura K, Hiramatsu N, Shigehara T, Takeuchi S, Tomioka M, Sakairi T, Yamashita S, Maeshima A, Kaneko Y, Kuroiwa T, Kopp JB, Nojima Y
Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy.
Am J Physiol Renal Physiol 293(4):F1214-21, 2007
Sakairi T, Hiromura K, Yamashita S, Takeuchi S, Tomioka M, Ideura H, Maeshima A, Kaneko Y, Kuroiwa T, Nangaku M, Takeuchi T, Nojima Y
Nestin expression in the kidney with an obstructed ureter.
Kidney Int 72(3):307-18, 2007
Maeshima A, Vaughn DA, Choi Y, Nigam SK
Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct.
Dev Biol 295(2): 473-85, 2006
Maeshima A, Sakurai H, Nigam SK
An adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into the developing Kidney.
J Am Soc Nephrol 17(1): 188-98, 2006
Yamashita S, Maeshima A, Nojima Y
Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys.
J Am Soc Nephrol 16(7): 2044-51, 2005
Ikeuchi H, Kuroiwa T, Yamashita S, Hiramatsu N, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y
Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: therapeutic implications for tubulointerstitial fibrosis.
Nephron Exp Nephrol 97(4): e115-122, 2004
Maeshima K, Maeshima A, Hayashi Y, Kishi S, Kojima I
Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor.
Endocrinology 145(8): 3739-45, 2004
Wada W, Maeshima A, Zhang YQ, Hasegawa Y, Kuwano H, Kojima I
Assessment of the function of the betaC-subunit of activin in cultured hepatocytes.
Am J Physiol Endocrinol Metab 287(2): E247-54, 2004
Yamashita S, Maeshima A, Kojima I, Nojima Y
Activin A is a potent activator of renal interstitial fibroblasts.
J Am Soc Nephrol 15(1): 91-101, 2004
Maeshima A, Yamashita S, Nojima Y
Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney.
J Am Soc Nephrol 14(12): 3138-3146, 2003
Ota F, Maeshima A, Yamashita S, Ikeuchi H, Kaneko Y, Kuroiwa T, Hiromura K, Ueki K, Kojima I, Nojima Y
Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
Arthritis Rheum 48(9): 2442-2449, 2003
Maeshima A, Yamashita S, Maeshima K, Kojima I, Nojima Y
Activin A produced by ureteric bud is a differentiation factor for metanephric mesenchyme.
J Am Soc Nephrol 14(6): 1523-1534, 2003
Maeshima A, Maeshima K, Nojima Y, Kojima I
Involvement of Pax-2 in the action of activin A on tubular cell regeneration.
J Am Soc Nephrol 13(12): 2850-2859, 2002
Zhang YQ, Zhang H, Maeshima A, Kurihara H, Miyagawa J, Takeuchi T, Kojima I
Up-regulation of the expression of activins in the pancreatic duct by reduction of the beta-cell mass.
Endocrinology 143(9): 3540-3547, 2002
Maeshima A, Nojima Y, Kojima I
Activin A: an autocrine regulator of cell growth and differentiation in renal proximal tubular cells.
Kidney Int 62(2): 446-454, 2002
Maeshima A, Zhang YQ, Nojima Y, Naruse T, Kojima I
Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats.
J Am Soc Nephrol 12(8): 1685-1695, 2001
Maeshima A, Zhang YQ, Furukawa M, Naruse T, Kojima I
Hepatocyte growth factor induces branching tubulogenesis in MDCK cells by modulating the activin-follistatin system.
Kidney Int 58(4): 1511-1522, 2000
Kogure K, Zhang YQ, Maeshima A, Suzuki K, Kuwano H, Kojima I
The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver.
Hepatology 31(4): 916-921, 2000
Maeshima A, Shiozaki S, Tajima T, Nakazato Y, Naruse T, Kojima I
Number of glomeruli is increased in the kidney of transgenic mice expressing the truncated type II activin receptor.
Biochem Biophys Res Commun 268(2): 445-449, 2000
Maeshima A, Murakami H, Sadakata H, Saitoh T, Matsushima T, Tamura J, Karasawa M, Naruse T
Eosinophilic gastroenteritis presenting with acute pancreatitis.
J Med 28(3-4): 265-272, 1997
著書
前嶋明人
「レジデントのための腎臓教室」ベストティーチャーに教わる全14章 日本医事新報社
2017年11月 初版 2023年7月 第2版
前嶋明人
かかりつけ医のための腎臓病診療ブラッシュアップ
2023年3月 金芳堂
Akito Maeshima
Daughter Cells: Properties, Characteristics and Stem Cells.
「Regeneration of the Kidney: Involvement of Intra-and Extra-Renal Stem Cells」 (pp.197-220) Novapublishers 2010
英文総説
Maeshima A, Takahashi S, Nakasatomi M, Nojima Y
Diverse Cell Populations Involved in Regeneration of Renal Tubular Epithelium Following Acute Kidney Injury.
Stem Cells Int. 2015: 964849. Review.
Maeshima A, Nakasatomi M, Nojima Y
Regenerative Medicine for the Kidney. Renotropic factors, renal stem/progenitor cells, and stem cell therapy.
Biomed Res Int. 2014: 595493. Review.
Maeshima A
Label-retaining cells in the kidney. Origin of regenerating cells after renal ischemia.
Clin Exp Nephrol 11(4): 269-74, 2007
Maeshima A, Miya M, Mishima K, Yamashita S, Kojima I, Nojima Y
Activin A: Autocrine Regulator of Kidney Development and Repair.
Endocr J 55(1):1-9, 2008
Maeshima A, Nojima Y, Kojima I
The role of the activin-follistatin system in the developmental and regeneration processes of the kidney.
Cytokine Growth Factor Rev 12(4): 289-298, 2002
Kojima I, Maeshima A, Zhang YQ
Role of the activin-follistatin system in the morphogenesis and regeneration of the renal tubules.
Mol Cell Endocrinol 180(1-2): 179-182, 2001
和文総説
前嶋明人
「高齢者の水・電解質異常」
Medical Practice 34巻11号
高橋駿介、前嶋明人
「腎障害における臨床的特徴と病理所見との関連」
リウマチ・膠原病診療ハイグレード「リウマチ・膠原病の合併症や諸問題を解く」76-83, 2016 文光堂
長田太助, 瀧史香, 前嶋明人, 田中哲洋
「慢性腎臓病（CKD）診療を極める CKDへの適切なアプローチと今後の治療の方向性」
内科 118巻1号 Page111-120
武井克仁, 前嶋明人
「腎再生医療の可能性と方向性」
Annual Review腎臓 2016巻 Page54-59
前嶋明人
「腎再生医療の実現を目指して」
The KITAKANTO MEDICAL JOURNAL 65:153-154, 2015
横尾隆, 長船健二, 西中村隆一, 前嶋明人
「腎臓再生医療の現状（座談会）」
Nephrology Frontier 14巻2号 Page110-117
前嶋明人、野島美久
差分解説「急性腎障害を反映する新規尿中バイオマーカー」
日本医事新報 No.4699 2014日本医事新報社
前嶋明人、野島美久
差分解説「腎再生医療に関する最近の知見」
日本医事新報 No.4693 2014日本医事新報社
前嶋明人、野島美久
知っておきたいことアラカルト「抗好中球細胞質抗体（ANCA）関連血管炎」
Medical Practice 31巻8号 Page1354-1356 2014文光堂
前嶋明人
ワンポイントアドバイス「蛋白尿・血尿 -腎臓専門医に紹介するタイミング-」
Medical Practice 30巻6号1098, 2013 文光堂
前嶋明人、野島美久
血液疾患と腎障害
内科学（第10版） 1475-1476, 2013 朝倉書店
前嶋明人、野島美久
溶血性尿毒症症候群
内科学（第10版） 1476-1477, 2013 朝倉書店
前嶋明人、野島美久
早期診断と治療「全身性エリテマトーデス」
内科 112巻1号33-37, 2013 南江堂
前嶋明人
実地医家のための臨床検査のすすめかた・評価のしかた「腎・泌尿器疾患 I. 症候から診断へ」
Medical Practice 2012年臨時増刊号 78-84, 2012 文光堂
前嶋明人、野島美久
「各種病態にみられる腎障害：血栓性血小板減少性紫斑病」別冊日本臨床新領域別症候群シリーズNo.18
腎臓症候群（第2版） 405−408, 2012 日本臨床社
前嶋明人、野島美久
アミロイド腎
腎・透析診療最新ガイドライン 総合医学社
前嶋明人、野島美久
「ループス腎炎の治療と予後」
リウマチ科 47巻5号 Page481-487, 2012 科学評論社
前嶋明人
Basic Nephrology尿細管再生に関する最近の知見
Annual Review腎臓2009 Page43-49 中外医学社
宮政明、前嶋明人
「尿細管細胞の再生機構」
Nephrology Frontier 7巻2号Page148-152
前嶋明人
「尿細管の再生療法への道」
医学のあゆみ 225巻4号Page317-320
池内秀和, 廣村桂樹, 坂入徹, 山下眞, 岡上準, 冨澤健史, 田村茂生, 前嶋明人, 金子和光, 黒岩卓, 植木嘉衛, 塚田義人, 河合弘進, 若松良二, 野島美久
「IgA腎症に対するステロイドパルス療法の有効性 腎機能低下症例における検討」
日本腎臓学会誌 50巻2号Page114-121
三島敬一郎、前嶋明人
「腎再生医学に関する最近の知見」第92回東京腎生理集談会
腎と透析 64巻3号Page417-421
宮政明、前嶋明人、野島美久
これだけは知っておきたい分子腎臓病学2007「幹細胞」
腎と透析 Vol.63 No.4, 510−513, 2007
前嶋明人
「腎尿細管再生機序の解明と腎幹細胞の同定」
北関東医学会誌 Vol.57 No.1 147-148, 2007
前嶋明人
「LRCsを起点とした尿細管再生プロセス」 腎の再生医学
医学のあゆみ Vol.220 No.6 491-495, 2007
前嶋明人、野島美久
血液浄化療法（下）アクチビン
日本臨床 62巻（増刊号6）201-205, 2004
前嶋明人、野島美久
アクチビンによる腎再生
腎臓ナビゲーター 290-291, 2004
前嶋明人
（総説）アクチビン・フォリスタチン系による腎尿細管形成と再生の制御
発達腎研究会雑誌 Vol. 11 No.1 6-10, 2003
前嶋明人、野島美久、小島至
アクチビン・フォリスタチン系制御による腎再生の試み
Nephrology Frontier Vol.1 No.3 30-35, 2002
前嶋明人、野島美久、小島至
腎の再生医学—アクチビン・フォリスタチン系による腎尿細管再生の制御— 発生学から再生医療へ
医学のあゆみ Vol.199 No.13 1107-1112, 2001
小島至・前嶋明人
（総説）アクチビンシグナリングと腎臓の形態形成・再生
蛋白質核酸酵素 vol.46 No.2 130-137, 2001
前嶋明人、野島美久、小島至
【再生医学のフロンティア】 腎臓の再生医学
Molecular Medicine Vol.38 No.1 68-76, 2001
和田渉、前嶋明人、小島至
（総説）フォリスタチンと再生医学
最新医学 vol.55 別冊 205-215, 2000
前嶋明人、小島至
（総説）「図解ホルモンのすべて」アクチビン・インヒビン
ホルモンと臨床 98‘春季増刊号p486-496
前嶋明人、小島至
（総説）体液性因子における骨・血管相互作用 -骨・血管とFGF-
Clinical Calcium vol.7 No.9 p32-37, 1997
前嶋明人、小島至
「ノックアウトマウス・データブック」 Follistatin
Molecular Medicine Vol.34 臨時増刊号 p178-179, 1997